Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Am Med Dir Assoc ; 15(3): 220-225, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24355078

ABSTRACT

OBJECTIVES: To assess the overall quality of life of long-stay nursing home residents with preserved cognition, to examine whether the Centers for Medicare and Medicaid Service's Nursing Home Compare 5-star quality rating system reflects the overall quality of life of such residents, and to examine whether residents' demographics and clinical characteristics affect their quality of life. DESIGN/MEASUREMENTS: Quality of life was measured using the Participant Outcomes and Status Measures-Nursing Facility survey, which has 10 sections and 63 items. Total scores range from 20 (lowest possible quality of life) to 100 (highest). SETTING/PARTICIPANTS: Long-stay nursing home residents with preserved cognition (n = 316) were interviewed. RESULTS: The average quality- of-life score was 71.4 (SD: 7.6; range: 45.1-93.0). Multilevel regression models revealed that quality of life was associated with physical impairment (parameter estimate = -0.728; P = .04) and depression (parameter estimate = -3.015; P = .01) but not Nursing Home Compare's overall star rating (parameter estimate = 0.683; P = .12) and not pain (parameter estimate = -0.705; P = .47). CONCLUSION: The 5-star quality rating system did not reflect the quality of life of long-stay nursing home residents with preserved cognition. Notably, pain was not associated with quality of life, but physical impairment and depression were.


Subject(s)
Nursing Homes , Quality of Health Care , Quality of Life , Activities of Daily Living , Aged , Centers for Medicare and Medicaid Services, U.S. , Cognition , Humans , Long-Term Care , Michigan , Middle Aged , Qualitative Research , Quality Indicators, Health Care , Regression Analysis , Surveys and Questionnaires , United States , Urban Health Services
2.
J Am Pharm Assoc (2003) ; 53(6): 626-31, 2013.
Article in English | MEDLINE | ID: mdl-24141382

ABSTRACT

OBJECTIVE: To explore whether racial disparity in osteoporosis drug therapy maintenance varies by health insurance coverage status. DESIGN: Longitudinal observation study. SETTING: Cleveland Clinic Health System (Cleveland, OH) from January 2006 to December 2009. PATIENTS: 3,901 black and white female Medicare beneficiaries starting osteoporosis drug therapy. INTERVENTION: Analysis of the health system's integrated electronic medical records. MAIN OUTCOME MEASURES: Drug therapy adherence (medication possession ratio ≥80%) for more than 12 of 15 surveillance units and occurrence of extended nonadherence gaps for at least two surveillance units in a row. RESULTS: Among patients with supplementary health insurance (n = 2,278), no difference was observed for drug therapy adherence ( P = 0.17) and extended nonadherence gaps ( P = 0.53) between black and white participants. When patients did not have supplementary health insurance (n = 1,623), blacks (36% [95% CI 28-47]) were less likely to adhere to drug therapy than whites (47% [38-57]; odds ratio [OR] 0.34 [95% CI 0.09-0.92], P = 0.004). Blacks (25% [19-32]) also were more likely to have an extended nonadherence gap episode than whites (18% [11-26]; OR 2.42 [1.13-3.50], P = 0.03). CONCLUSION: Similar to previous research on racial disparity in health services, racial disparity in osteoporosis drug therapy maintenance between black and white female older patients existed when supplementary health insurance was not affordable.


Subject(s)
Black or African American/statistics & numerical data , Medication Adherence/statistics & numerical data , Osteoporosis/drug therapy , White People/statistics & numerical data , Aged , Aged, 80 and over , Electronic Health Records , Female , Humans , Insurance Coverage/statistics & numerical data , Insurance, Health/statistics & numerical data , Longitudinal Studies , Medicare , Medication Adherence/ethnology , Ohio , United States
3.
J Am Med Dir Assoc ; 14(9): 710.e1-4, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23860264

ABSTRACT

BACKGROUND: To identify the factors associated with stay in a skilled nursing facility (SNF) among new enrollees who did not fully participate in therapy sessions. METHODS: Data (n = 36,133) were obtained from the Minimum Data Set version 2.0 in the state of Michigan in 2009. Study participants were new SNF enrollees (n = 699) who did not fully participate in therapy sessions despite their desire to return to the community. Multivariate logistic regressions were performed to identify factors contributing to remaining in a nursing home for 91 days or longer. RESULTS: New SNF enrollees were more likely to remain in nursing home when they were depressed (odds ratio [OR] = 1.41; 95% confidence interval [CI], 1.09-2.08; P = .01), experiencing delirium (OR = 3.20; 95% CI, 1.48-5.92; P < .001), were not in pain (OR = 0.83; 95% CI, 0.60-0.95; P = .03), or in less complex care (OR = 0.57; 95% CI, 0.44-0.81; P < .01). CONCLUSIONS: A higher number of new SNF enrollees than previously reported were likely to stay in nursing homes (28.0%). Depression and delirium were associated with stay in an SNF, while pain and higher complexity of care were associated with returning to the community.


Subject(s)
Length of Stay/statistics & numerical data , Patient Acceptance of Health Care , Skilled Nursing Facilities , Aged , Aged, 80 and over , Delirium/epidemiology , Depression/epidemiology , Female , Humans , Male , Michigan/epidemiology , Pain Measurement , Risk Factors
4.
Bull Environ Contam Toxicol ; 88(1): 112-7, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22002114

ABSTRACT

We investigated the effects of Cistanches herba (CH) on the male reproductive system in mice, assessing CREM gene expression and spermatogenesis. Our results demonstrate that CH treatment lead to a significant decrease in sperm count dose-dependently, 298.3 ± 48.9 vs. 296.6 ± 102.4 (250 mg/kg), 236.7 ± 75.1 (500 mg/kg), 223.0 ± 48.7 × 10(6) (1000 mg/kg), respectively. Additionally, serum testosterone levels decreased following CH treatment to as low as ~57% compared with the vehicle-treated group. CREM gene expression was also down-regulated following CH treatment and histological examination of the testicular seminiferous tubules showed severe damage on CH treatment. These results suggest that CH induces cytotoxicity in the male reproductive system, through the inhibition of spermatogenesis, testicular damage, and limited hormonal function.


Subject(s)
Cistanche , Cytotoxins/toxicity , Drugs, Chinese Herbal/toxicity , Testis/drug effects , Animals , Cyclic AMP Response Element Modulator/genetics , Cyclic AMP Response Element Modulator/metabolism , Dose-Response Relationship, Drug , Free Radical Scavengers/toxicity , Gene Expression/drug effects , Male , Mice , Neuroprotective Agents/toxicity , Spermatogenesis/drug effects , Testis/metabolism , Testosterone/genetics , Testosterone/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...